This position leads the medical strategy for assigned oncology indication(s)/asset(s), driving launch excellence, shaping evidence generation, and building confidence in our science across the globe.

Acting as the key bridge between R&D and Commercial, this role steers the Global Medical Plan, orchestrates global launch readiness, and ensures that every decision is grounded in robust data and patient impact.

Ready to influence how new oncology medicines are understood, adopted, and scaled across diverse healthcare systems?

Accountabilities

• Provide strategic medical leadership for assigned indication(s)/asset(s), owning the Global Medical Plan and leading launch strategy from early planning through post-launch optimisation.

• Set clear strategic direction, prioritise initiatives, and make evidence-based trade-offs to maximise patient outcomes and business impact, adapting plans in response to external dynamics and performance against launch KPIs.

• Define, track, and interpret medical Key Performance Indicators to assess strategy impact, identify progress, and diagnose barriers to launch success.

• Represent Global Medical on key cross-functional forums such as the Integrated Business Team and Global Product Team, shaping commercial strategy, informing R&D development and lifecycle planning, and ensuring Medical input into clinical development and commercialisation strategies.

• Lead Medical Integrated Teams to align global, regional, and country medical teams around launch strategy and execution, acting as a medical decision-maker and ambassador in market engagements.

• Influence clinical development by identifying registrational evidence gaps, companion study needs, and Target Product Profile implications, ensuring Medical perspectives shape Tumor Strategic Plans and Business Strategy Plans.

• Strengthen global medical capabilities through effective delegation, coaching, empowerment, and mentorship, building high-performing teams focused on launch excellence.

• Lead global and regional evidence gap analyses to define critical clinical, real-world, and mechanistic evidence needs, and develop integrated evidence plans across clinical, diagnostic, digital, and real-world sources.

• Shape the scientific and strategic design of AZ-sponsorised interventional Medical Affairs studies, conceptualise real-world evidence studies with partners, and oversee governance, milestones, and resources to deliver to the highest scientific, ethical, and compliance standards.

• Own the Global Publications Plan from Phase 3 ID onwards in partnership with publications teams, ensuring compelling, credible scientific communications and appropriate review of local/regional medical studies and Externally Sponsored Research.

• Embed innovative approaches to evidence generation aligned with the MARS vision, leveraging cancer networks, novel study designs, and data-driven insights.

• Own and lead the scientific narrative from pre-Phase 3 ID onwards, ensuring consistency across evidence, publications, congresses, and education while driving an Integrated Confidence Plan executed by Centres of Excellence.

• Define global medical education priorities, identify key audiences and learning objectives, guide delivery formats (digital, hybrid, in-person), and ensure scientific rigor in all educational activities.

• Lead the external engagement strategy for indication(s)/asset(s), including KEEs, societies, health systems, and global organisations; gather insights that shape scientific practice and actively influence external experts to advance health outcomes and accelerate guideline adoption.

• Lead congress strategy end-to-end: drive pre-congress planning (abstracts, presentations, training), guide on-site scientific presence, and oversee post-congress insight synthesis, dissemination, and follow-up actions.

Essential Skills/Experience

• Advanced degree required (MD, PhD, PharmD, in any related field)

• At least three years of experience within the pharmaceutical or biotech industry, ideally at the country, Region and global level.

• Demonstrated success in leading evidence generation strategies, Medical Plans, publications, or scientific communication programs.

• Proven ability to influence senior stakeholders across Commercial, R&D, and Medical Affairs.

• Experience engaging external experts and scientific communities.

Desirable Skills/Experience

• Previous global Medical Affairs leadership experience in oncology.

• Experience leading cross-functional teams in highly complex, multi-indication environments.

• Experience navigating launch environments, new MoAs, new CDx, complex biomarker landscapes, or challenging safety profiles (aligning to GMAL complexity criteria).

Benefits

AstraZeneca offers an environment where scientific curiosity meets real-world impact: a global biopharmaceutical company tackling serious disease while constantly searching for new ways to solve complex healthcare and sustainability challenges.

Teams reflect the diversity of the communities we serve; different perspectives are encouraged, collaboration is expected, and questioning minds are supported to push boundaries.

With strong investment in learning, data and digital innovation, and cross-functional partnerships inside and outside the organisation, people are empowered to take smart risks, learn fast from experience, and contribute directly to life-changing medicines for patients worldwide.

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.

We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.

We follow all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

XML job scraping automation by YubHub

The ideal candidate is a professional with a proven track record identifying the KOLs and payors nationally, and addressing the clinical knowledge gaps across a wide range of customers by communicating impactful scientific information. You are passionate about patient care, and you will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.

Responsibilities:

• Identify and develop relationships with key decision makers in academic and community clinics, hospital systems, payor/managed care organizations, and other institutions that influence or manage the use of screening products.
• Collaborate with clinical and payor customers to understand their needs, knowledge gaps, challenges, and evidence requirements for clinical integration, reimbursement, and coverage.
• Develop timely and strategic territory/account plans to address customer needs.
• Educate and conduct meaningful scientific exchange with clinicians on the clinical attributes of Freenome products.
• Educate managed care/payors on the clinical value of Freenome products and services to drive plan inclusion and appropriate utilization.
• Providing support for on-site oral presentations, data reviews, and interactive education events for Key Opinion Leaders (KOLs).

Thought Leadership and Industry Awareness:

• Stay abreast of the latest scientific and clinical advancements, market trends, and regulatory guidelines relevant to our products, specifically in relation to market access, clinical, IDN, and payor environments.
• Represent the company at industry conferences, meetings, and other events as a thought leader and fostering key relationships.
• Assist in organizing forums and events for KOLs to discuss clinical challenges, unmet needs, and potential product improvements.
• Identify trends impacting patient access to blood-based cancer screening.
• Critically reviewing new publications and research findings to help develop educational slides, which are then submitted for approval to Medical Affairs and Marketing.

Strategic Partnerships:

• Collaborating with Sales executives to identify and advise on strategic partnership opportunities.
• Promote effective compliant collaboration with key internal and external stakeholders.
• Close strategic and tactical alignment with commercial field-based teams to ensure appropriate medical support.
• Build field medical territories for commercial launch.

Investigator Initiated Studies:

• Identify investigator initiated study proposals that align with Freenome SMA strategies.
• Present investigator study proposals to cross functional partners in clinical development and scientific medical affairs in support of research activities, including clinical trials, registries, ISTs, and/or RWE.

Must haves:

• Advanced degree in medical or health sciences (e.g. MS/MD/DO/PhD/PharmD).
• 5+ years relevant industry (diagnostic, pharmaceutical, oncology) experience required.
• Medical science liaison experience (oncology/diagnostic industries).
• In-depth scientific and/or therapeutic knowledge.
• Demonstrated understanding of clinical trial management.
• Working knowledge of regulatory guidance and reporting requirements.
• Exceptional organizational and time management skills.
• Strong presentations skills including excellent verbal and written communication.
• Strong interpersonal skills and demonstrated ability to work effectively in a cross functional team.
• A self-starter with a results-driven mentality and positive attitude.
• Computer proficiency in Excel, Word, PowerPoint, Adobe and Google’s office (Drive, Sheets, Docs, Slides, Forms).

Nice to haves:

• Existing relationships with key opinion leaders and affiliated institutions.

Benefits and additional information:

• The US target range of our base salary for new hires is $182,750 - $257,250. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered.

XML job scraping automation by YubHub